Literature DB >> 20978263

Clopidogrel and the reduced-function CYP2C19 genetic variant: a limited piece of the overall therapeutic puzzle.

Valentin Fuster, Joseph M Sweeny.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978263     DOI: 10.1001/jama.2010.1566

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

Review 1.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John W Eikelboom; Jack Hirsh; Frederick A Spencer; Trevor P Baglin; Jeffrey I Weitz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Genetics of peripheral artery disease.

Authors:  Nicholas J Leeper; Iftikhar J Kullo; John P Cooke
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

Review 3.  Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.

Authors:  Frank S Ong; Joshua L Deignan; Jane Z Kuo; Kenneth E Bernstein; Jerome I Rotter; Wayne W Grody; Kingshuk Das
Journal:  Pharmacogenomics       Date:  2012-03       Impact factor: 2.533

Review 4.  Ticagrelor: a review of its use in the management of acute coronary syndromes.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

Review 5.  Pharmacogenetics of antiplatelet therapy.

Authors:  Patrick L Daly; Richard C Becker
Journal:  Curr Atheroscler Rep       Date:  2014-05       Impact factor: 5.113

6.  Pharmacogenomics: application to the management of cardiovascular disease.

Authors:  J A Johnson; L H Cavallari; A L Beitelshees; J P Lewis; A R Shuldiner; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2011-09-14       Impact factor: 6.875

Review 7.  The pharmacogenetics of antiplatelet agents: towards personalized therapy?

Authors:  Tariq Ahmad; Deepak Voora; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

Review 8.  Genomics and drug response.

Authors:  Liewei Wang; Howard L McLeod; Richard M Weinshilboum
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

Review 9.  A review of pharmacogenetics of adverse drug reactions in elderly people.

Authors:  Maurizio Cardelli; Francesca Marchegiani; Andrea Corsonello; Fabrizia Lattanzio; Mauro Provinciali
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

Review 10.  Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Authors:  Mohamed H A Shahin; Julie A Johnson
Journal:  Curr Opin Cardiol       Date:  2013-05       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.